piracetam has been researched along with Hepatic Porphyria in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a patient with focal epilepsy and latent hereditary coproporphyria who had exacerbation of clinical symptoms of porphyria under treatment with valproate and primidone and was then treated with levetiracetam without exacerbation of clinically latent porphyria." | 5.32 | Levetiracetam in focal epilepsy and hepatic porphyria: a case report. ( Meencke, HJ; Paul, F, 2004) |
| "We report a patient with focal epilepsy and latent hereditary coproporphyria who had exacerbation of clinical symptoms of porphyria under treatment with valproate and primidone and was then treated with levetiracetam without exacerbation of clinically latent porphyria." | 1.32 | Levetiracetam in focal epilepsy and hepatic porphyria: a case report. ( Meencke, HJ; Paul, F, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paul, F | 1 |
| Meencke, HJ | 1 |
1 other study available for piracetam and Hepatic Porphyria
| Article | Year |
|---|---|
Levetiracetam in focal epilepsy and hepatic porphyria: a case report.
Topics: Acute Disease; Adult; Anticonvulsants; Comorbidity; Epilepsies, Partial; Female; Humans; Levetiracet | 2004 |